Bitcoin and other cryptocurrencies experienced a slight decline on Thursday, remaining close to crucial levels as a "sell the news" trend continued following the approval of spot Bitcoin exchange-traded funds. There is a possibility of further selling in the near future.
Over the past 24 hours, the price of Bitcoin dropped by less than 1% and fell below the $39,800 mark. Although it dipped below the psychologically significant $40,000 threshold, it managed to stay above recent lows in the $38,000 range. Despite this, the leading digital asset is still more than 15% lower than its peak of over $48,000, reached during the trading frenzy surrounding the anticipation and eventual approval of spot Bitcoin ETFs in the United States.
Earlier this week, the optimism surrounding risk-sensitive assets and the stock market rally, with the Dow Jones Industrial Average and S&P 500 trading near their all-time highs, boosted cryptocurrencies. However, these gains were not sustained. Currently, Bitcoin is hovering around the pivotal $40,000 level. Although recent price movements have been negative, there is a sense of stability in the short term. However, this stability may not last long.
According to Alex Kuptsikevich, an analyst at broker FxPro, Bitcoin has shown a cautious upward trend since Tuesday. Some traders are aiming to secure profits from short positions or buy after a sharp sell-off. It is worth noting that Bitcoin did not become oversold before stabilizing, and bears may be taking advantage of the current lull to accumulate liquidity before initiating another sell-off.
Apart from Bitcoin, Ether, the second-largest cryptocurrency, experienced a 1% drop to reach $2,200. Smaller tokens or altcoins showed less movement. Cardano was slightly above flat, while Polygon was just below it. Among memecoins, Dogecoin saw a 2% decrease, whereas Shiba Inu advanced by more than 1%.
In conclusion, Bitcoin's recent performance has been impacted by the approval of spot Bitcoin exchange-traded funds, leading to a "sell the news" dynamic. Although it is currently holding near key levels, a potential further decline looms. Traders are cautiously observing the market, taking profits and preparing for future volatility.
Our Latest News
VYNE Therapeutics announces positive results from a Phase 1b trial of VYN201 in vitiligo patients, highlighting its potential in addressing skin depigmentation...
Ray Dalio draws parallels between the West's restrictions on Chinese access to microchips and US policies towards Japan in the 1940s, highlighting the potential...
Berkshire Hathaway Inc. Cl B stock declined for the second consecutive day amidst a general downturn in the stock market. Trading volume remained slightly below...